These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6795261)

  • 21. Maleylated bovine serum albumin triggers cytolytic function in selected populations of primed murine macrophages.
    Somers SD; Hamilton TA; Adams DO
    J Immunol; 1987 Aug; 139(4):1361-8. PubMed ID: 3112232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
    Lu CY; Lombardi MJ; Shea CM; Dustin LB
    J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis.
    Johnson WJ; Bolognesi DP; Adams DO
    Cell Immunol; 1984 Jan; 83(1):170-80. PubMed ID: 6420078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of bacterial lipopolysaccharide and lymphokine in the regulation of macrophage activation: correlates between secretion of plasminogen activator and tumor lysis.
    Jones CM; Taramelli D; Clouse CA; Goldfarb RG
    Immunobiology; 1984 May; 166(4-5):410-27. PubMed ID: 6541192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells.
    Balk SP; Mescher MF
    J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
    Lee KC; La Posta VJ
    J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of tumor binding by the IC-21 macrophage cell line.
    Crawford EK; Latham PS; Shah EM; Hasday JD
    Cancer Res; 1990 Aug; 50(15):4578-83. PubMed ID: 2164442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD; Yoon HJ; Kim HM; Chung HT
    Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokinetics of macrophage-mediated cytotoxicity.
    Normann SJ; Cornelius J
    Cancer Res; 1984 Jun; 44(6):2313-9. PubMed ID: 6426778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ; Cornelius J
    Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Killing of virus-induced thymic lymphoma cells obtained from primary and early transfers by activated macrophages.
    Boteach D; Gallily R
    Isr J Med Sci; 1988; 24(9-10):518-21. PubMed ID: 3264552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.